Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Clinical effects of gemifloxacin on the delay of tuberculosis treatment.

Kim SY, Yim JJ, Park JS, Park SS, Heo EY, Lee CH, Chung HS, Kim DK.

J Korean Med Sci. 2013 Mar;28(3):378-82. doi: 10.3346/jkms.2013.28.3.378. Epub 2013 Mar 4.

PMID:
23486643
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.

Yoo BK, Triller DM, Yong CS, Lodise TP.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1226-35. Epub 2004 Jun 8. Review.

PMID:
15187209
[PubMed - indexed for MEDLINE]
3.

Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia.

Yoon YS, Lee HJ, Yoon HI, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Int J Tuberc Lung Dis. 2005 Nov;9(11):1215-9.

PMID:
16333927
[PubMed - indexed for MEDLINE]
4.

Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones.

Grossman RF, Hsueh PR, Gillespie SH, Blasi F.

Int J Infect Dis. 2014 Jan;18:14-21. doi: 10.1016/j.ijid.2013.09.013. Epub 2013 Oct 26. Review.

PMID:
24211230
[PubMed - indexed for MEDLINE]
Free Article
5.

Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.

Zhang L, Wang R, Falagas ME, Chen LA, Liu YN.

Chin Med J (Engl). 2012 Feb;125(4):687-95. Erratum in: Chin Med J (Engl). 2013 Aug;126(16):3018. Matthew, Falagas E [corrected to Falagas, Matthew E].

PMID:
22490497
[PubMed - indexed for MEDLINE]
Free Article
6.

Gemifloxacin for community-acquired pneumonia.

Lode HM, Schmidt-Ionas M, Stahlmann R.

Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779 . Review.

PMID:
18447602
[PubMed - indexed for MEDLINE]
8.
9.

Role of gemifloxacin in community-acquired pneumonia.

Tillotson GS.

Expert Rev Anti Infect Ther. 2008 Aug;6(4):405-18. doi: 10.1586/14787210.6.4.405. Review.

PMID:
18662107
[PubMed - indexed for MEDLINE]
10.
11.

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

Ball P, Mandell L, Patou G, Dankner W, Tillotson G.

Int J Antimicrob Agents. 2004 May;23(5):421-9. Review.

PMID:
15120718
[PubMed - indexed for MEDLINE]
12.

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

File TM Jr, Mandell LA, Tillotson G, Kostov K, Georgiev O.

J Antimicrob Chemother. 2007 Jul;60(1):112-20. Epub 2007 May 30.

PMID:
17537866
[PubMed - indexed for MEDLINE]
Free Article
13.

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions.

Shen GH, Tsao TC, Kao SJ, Lee JJ, Chen YH, Hsieh WC, Hsu GJ, Hsu YT, Huang CT, Lau YJ, Tsao SM, Hsueh PR.

Int J Antimicrob Agents. 2012 Mar;39(3):201-5. doi: 10.1016/j.ijantimicag.2011.11.014. Epub 2012 Jan 28. Review.

PMID:
22285045
[PubMed - indexed for MEDLINE]
14.

Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.

Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR.

Clin Infect Dis. 2002 Jun 15;34(12):1607-12. Epub 2002 May 23.

PMID:
12032896
[PubMed - indexed for MEDLINE]
Free Article
15.

Gemifloxacin: a new fluoroquinolone.

Blondeau JM, Missaghi B.

Expert Opin Pharmacother. 2004 May;5(5):1117-52.

PMID:
15155113
[PubMed - indexed for MEDLINE]
16.

Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infections.

File TM Jr, Tillotson GS.

Expert Rev Anti Infect Ther. 2004 Dec;2(6):831-43. Review.

PMID:
15566328
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.

File TM Jr, Schlemmer B, Garau J, Cupo M, Young C; 049 Clinical Study Group.

J Antimicrob Chemother. 2001 Jul;48(1):67-74.

PMID:
11474633
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.

Jivcu C, Gotfried M.

Int J Chron Obstruct Pulmon Dis. 2009;4:291-300. Epub 2009 Aug 3. Review.

PMID:
19684863
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.

Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS.

Int J Antimicrob Agents. 2004 Jun;23(6):533-46. Review.

PMID:
15194123
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk